Skip to main content

and
  1. No Access

    Article

    Advances in the treatment of polymyalgia rheumatica and giant cell arteritis

    Research published in 2023 has demonstrated the efficacy of sarilumab for IL-6 blockade in polymyalgia rheumatica and of secukinumab for IL-17 blockade in giant cell arteritis (GCA). Furthermore, preliminary r...

    Lindsay Lally, Robert Spiera in Nature Reviews Rheumatology (2024)